Evidence map›Paper›PMID 35325283›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2022

Feasibility of [

Lena M Unterrainer, Simon Lindner, Lennert Eismann, Jozefina Casuscelli, Franz-Josef Gildehaus, Vinh Ngoc Bui, Nathalie L Albert, Adrien Holzgreve, Leonie Beyer, Andrei Todica and 9 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Potential value of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  4. [Innovative imaging techniques for urothelial carcinoma].Urologie (Heidelberg, Germany) · 2026
    Review
  5. Review
  6. European journal of nuclear medicine and molecular imaging · 2025
    Article
  7. Review
  8. Review
  9. Is There a Role for FAPI PET in Urological Cancers?Molecular diagnosis & therapy · 2024
    Review
  10. [European journal of nuclear medicine and molecular imaging · 2024
    Article
  11. [European journal of nuclear medicine and molecular imaging · 2024
    Article
  12. Review
  13. Initial Experience withJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  14. Review
  15. Fully automated radiosynthesis of [EJNMMI radiopharmacy and chemistry · 2023
    Article
  16. Review
  17. PET Imaging in Bladder Cancer: An Update and Future Direction.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Lena M UnterrainerDepartment of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Lena.Unterrainer@med.uni-muenchen.de.
Simon LindnerDepartment of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Lennert EismannDepartment of Urology, University Hospital, LMU Munich, Munich, Germany.
Jozefina CasuscelliDepartment of Urology, University Hospital, LMU Munich, Munich, Germany.
Franz-Josef GildehausDepartment of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Vinh Ngoc BuiDepartment of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Nathalie L AlbertDepartment of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Adrien HolzgreveDepartment of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Leonie BeyerDepartment of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Andrei TodicaDepartment of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Matthias BrendelDepartment of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Clemens C CyranDepartment of Radiology, University Hospital, LMU Munich, Munich, Germany.
Alexander KarlDepartment of Urology, Krankenhaus Barmherzige Brüder, Munich, Germany.
Christian G StiefDepartment of Urology, University Hospital, LMU Munich, Munich, Germany.
Stephan T LedderoseInstitute of Pathology, LMU Munich, Munich, Germany.
Marcus UnterrainerDepartment of Radiology, University Hospital, LMU Munich, Munich, Germany.
Peter BartensteinDepartment of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Vera Wenter *Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Alexander Kretschmer *Department of Urology, University Hospital, LMU Munich, Munich, Germany.
Ludwig-Maximilians-Universität München · DELMU Klinikum · DEKrankenhaus Barmherzige Brüder · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background[

methodsFifteen patients with UC prior to or after local treatment underwent [

resultsOverall, 64 tumor sites were detected on PET and/or CT. The highest uptake intensity was noted at the primary site (SUV

conclusion[

Indexed as

Carcinoma, Transitional CellUrinary Bladder NeoplasmsFeasibility StudiesFluorodeoxyglucose F18Gallium RadioisotopesHumansPositron Emission Tomography Computed TomographyQuinolinesTissue DistributionFAPI-46Fluorodeoxyglucose F18Gallium RadioisotopesQuinolinesFAPIFibroblast activating proteinMetastatic urothelial carcinomaPET/CT imagingUrothelial carcinoma

Identifiers

PMID35325283
PMCPMC9308618
OpenAlexW4220828740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.